Breaking News, Promotions & Moves

GC Therapeutics Appoints Stefan Irion Chief Scientific Officer

Irion brings more than two decades of experience in translating stem cell science into clinical-stage therapeutics.

Author Image

By: Patrick Lavery

Content Marketing Editor

GC Therapeutics is naming Stefan Irion, PhD, its new Chief Scientific Officer. Irion joins from BlueRock Therapeutics, where he occupied the same post and also served on that company’s executive committee. At GC, the TFome (Transcription-Factor-ome) induced pluripotent stem cell (iPSC) programming platform is the company’s contribution to next-generation cell-based medicines. It enables expansion into in-vivo rejuvenation and reprogramming. Irion’s Experience Irion brings to G...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters